Truscreen Group Ltd (TRU)
20mins delayed
Movement
1 Year Return
Truscreen Group Ltd Chart
Share price | |
Last | |
Change | |
Volume | |
Turnover | |
Market Cap | $50.8 million |
Today's Movement | |
Prev. Close | |
Open | |
Day Range | - |
VWAP |
Historical Stats | |
52w Range | - |
4w Avg Volume | |
4w Avg Turnover | |
(delayed) |
TRU Statistics
15 January
1,311 / 2,260
ASX Size Rank
1yr Return
vs Sector (1yr)
+34.20%
vs ASX 200 (1yr)
+50.47%
$50.8 million
Market Cap
Share Issue
362.87 million
All Ords (%)
N/A
Short Sold
0%
Current Fundamentals
15 January
N/A
PE Ratio
EPS ($)
-
Earnings Yield
-
NTA ($)
-
0.00%
Dividend Yield
DPS ($)
-
Gross Div. Yield
-
Gross DPS ($)
-
Company Overview
Truscreen Group Limited (TRU) is the manufacturer and owner of the TruScreen Cervical Cancer Screening System. TruScreen's real time cervical cancer technology utilises a digital wand which is placed on the surface of the cervix to measure electrical and optical signals from the surrounding tissue.

Upcoming Calendar
Dividend History
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
No dividends paid in the last 5 years |
See Upcoming Dividends for all ASX companies.
Announcements
Date | Heading | Pages | File Size | Time |
---|---|---|---|---|
Announcements provided by

Broker Consensus
The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.
TRU is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.
Directors & Management
Director Transactions
TRU directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
There are no director transactions for code TRU in our database.
Shareholder Distribution
Shareholder Distribution data is unavailable.
Top 20 Shareholders
Name | Shares | Capital |
---|---|---|
New Zealand Depository Nominee | 30,362,441 | 8.41% |
Consolidated Nominees Pty Ltd (i) | 29,539,900 | 8.18% |
New Zealand Central Securities Depository Limited | 23,049,754 | 6.39% |
Browns Island Holdings Limited | 22,400,000 | 6.21% |
Waitara Trustees Limited | 18,622,222 | 5.16% |
Masfen Securities Limited | 13,499,645 | 3.74% |
Albert Nominees Limited | 11,000,000 | 3.05% |
Consolidated Nominees Pty Ltd (ii) | 10,062,500 | 2.79% |
Forsyth Barr Custodians Limited | 10,003,610 | 2.77% |
Idl Trustee Limited | 9,850,000 | 2.73% |
Maarten Arnold Janssen | 4,964,170 | 1.38% |
Ryan Peter Parkin | 4,665,428 | 1.29% |
David Russell Stewart & Adrienne Ruth Stewart | 4,138,995 | 1.15% |
Melda Super Pty Limited | 3,500,000 | 0.97% |
Caroline Robyn Ball & Christopher John Thomson Bush | 2,978,681 | 0.83% |
Anthony Peng Ho & Chui Hoong Ho | 2,400,000 | 0.66% |
Custodial Services Limited | 2,367,499 | 0.66% |
Mark David John Williams | 2,321,429 | 0.64% |
Qsp Limited | 2,312,790 | 0.64% |
Timothy James Macintosh | 2,276,619 | 0.63% |
All other shareholders | 41.72 % |
The Top 20 Shareholders of TRU hold 58.28% of shares on issue.
TRU Share Price History
Date | Close | Change | % Change | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
TRU Historical Data
Download up to 20 years of share price history.
Year | Closing Price (30 June) | Last Trade |
---|
Offical data as published by ASX. See more Data Downloads.
Company Details
Principal Activity: The development, manufacture and sale of cancer detection devices and systems.
Incorporated: --
Suite 506, Level 5, 50 Clarence St
Sydney NSW 2000

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.